Thyroglobulin may affect telomerase activity in thyroid follicular cells

References

• NW Kim, MA Piatyszek, KR Prowse, CB Harley, MD West, PL Ho, GM Coviello, WE Wright, SL Weinrich, and JW Shay. (1994). Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011–2015.
   PubMed Web of Science ®Google Scholar
• AG Bodnar, M Ouellette, M Frolkis, SE Holt, CP Chiu, GB Morin, CB Harley, JW Shay, S Lichtstei, and WE Wright. (1998). Extension of life-span by introduction of telomerase into normal human cells. Science 279:349–352.
   PubMed Web of Science ®Google Scholar
• T Kiyono, SA Foster, JI Koop, JK McDougall, DA Galloway, and AJ Klingelhutz. (1998). Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396:84–88.
   PubMed Web of Science ®Google Scholar
• TM Nakamura, GB Morin, KB Chapman, SL Weinrich, WH Andrews, J Lingner, CB Harley, and TR Cech. (1997). Telomerase catalytic subunit homologs from fission yeast and human. Science 277:955–959.
   PubMed Web of Science ®Google Scholar
• M Meyerson, CM Counter, EN Eaton, LW Ellisen, P Steiner, SD Caddle, L Ziaugra, RL Beijersbergen, MJ Davidoff, Q Liu, S Bacchetti, DA Haber, and RA Weinberg. (1997). hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90:785–795.
   PubMed Web of Science ®Google Scholar
• J Feng, WD Funk, SS Wang, SL Weinrich, AA Avilion, CP Chiu, RR Adams, E Chang, RC Allsopp, J Yu, S Le, MD West, CB Harley, WH Andrews, CW Greider, and B Villeponteau. (1995). The RNA component of human telomerase. Science 269:1236–1241.
   PubMed Web of Science ®Google Scholar
• C Autexier, R Pruzan, WD Funk, and CW Greider. (1996). Reconstitu-tion of human telomerase activity and identification of a minimal functional region of the human telomerase RNA. EMBO J 15:5928–5935.
   PubMed Web of Science ®Google Scholar
• K Collins, and L Gandhi. (1998). The reverse transcriptase component of the tetrahymena telomerase ribonucleoprotein complex. Proc Natl Acad Sci USA 95:8485–8490.
   PubMedGoogle Scholar
• L Harrington, T McPhail, V Mar, W Zhou, R Oulton, MB Bass, I Arruda, and MO Robinson. (1997). A mammalian telomerase-associated protein. Science 275:973–977.
   PubMed Web of Science ®Google Scholar
• A Kilian, DD Bowtell, HE Abud, GR Hime, DJ Venter, PK Keese, EL Duncan, RR Reddel, and RA Jefferson. (1997). Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 6:2011–2019.
   PubMed Web of Science ®Google Scholar
• I Okayasu, T Osakabe, M Fujiwara, H Fukuda, M Kato, and M Oshimura. (1997). Significant correlation of telomerase activity in thyroid papillary carcinomas with cell differentiation, proliferation and extrathyroidal extension. Jpn J Cancer Res 88:965–970.
   PubMedGoogle Scholar
• M Saji, WH Westra, H Chen, CB Umbricht, RM Tuttle, MF Box, R Udelsman, S Sukumar, and MA Zeiger. (1997). Telomerase activity in the differential diagnosis of papillary carcinoma of the thyroid. Surgery 122:1137–1140.
   PubMedGoogle Scholar
• AJ Cheng, JD Lin, T Chang, and TC Wang. (1998). Telomerase activity in benign and malignant human thyroid tissues. Br J Cancer 77:2177–2180.
   PubMedGoogle Scholar
• MA Zeiger, RC Smallridge, DP Clark, CK Liang, SE Carty, CG Watson, R Udelsman, and M Saji. (1999). Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms. Surgery 126:1195–1199.
   PubMedGoogle Scholar
• M Kammori, K Nakamura, M Hashimoto, T Ogawa, M Kaminishi, and K Takubo. (2003). Clinical application of human telomerase reverse transcriptase gene expression in thyroid follicular tumors by fine-needle aspirations using in situ hybridization. Int J Oncol 22:985–991.
   PubMedGoogle Scholar
• K Ogisawa, N Onoda, T Ishikawa, C Takenaka, M Inaba, Y Ogawa, and KH Chung. (2002). Establishment and characterization of OCUT-1, an undifferentiated thyroid cancer cell line expressing high level of telomerase. J Surg Oncol 80:197–203.
   PubMedGoogle Scholar
• AM Straight, A Patel, C Fenton, C Dinauer, RM Tuttle, and GL Francis. (2002). Thyroid carcinomas that express telomerase follow a more aggressive clinical course in children and adolescents. J Endocrinol Invest 25:302–308.
   PubMed Web of Science ®Google Scholar
• BR Haugen, S Nawaz, N Markham, T Hashizumi, AL Shroyer, B Werness, and KR Shroyer. (1997). Telomerase activity in benign and malignant thyroid tumors. Thyroid 7:337–342.
   PubMedGoogle Scholar
• CY Lo, KY Lam, KT Chan, and JM Luk. (1999). Telomerase activity in thyroid malignancy. Thyroid 9:1215–1220.
   PubMedGoogle Scholar
• T Sugino, K Yoshida, J Bolodeoku, D Tarin, and S Goodison. (1997). Telomerase activity and its inhibition in benign and malignant breast lesions. J Pathol 183:57–61.
   PubMed Web of Science ®Google Scholar
• WE Wright, JW Shay, and MA Piatyszek. (1995). Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucl Aci Res 23:3794–3795.
   PubMed Web of Science ®Google Scholar
• P Brousset, N Chaouche, F Leprat, F Branet-Brousset, H Trouette, RC Zenou, JP Merlio, and G Delsol. (1997). Telomerase activity in human thyroid carcinomas originating from the follicular cells. J Clin Endocrinol Metab 82:4214–4216.
   PubMedGoogle Scholar
• X De Deken, C Vilain, J Van Sande, JE Dumont, and F Miot. (1998). Decrease of telomere length in thyroid adenomas without telomerase activity. J Clin Endocrinol Metab 83:4368–4372.
   PubMedGoogle Scholar
• Y Horikawa, N Oda, L Yu, S Imamura, K Fujiwara, M Makino, Y Seino, M Itoh, and J Takeda. (2003). Genetic variations in calpain-10 gene are not a major factor in the occurrence of type 2 diabetes in Japanese. J Clin Endocrinol Metab 88:244–247.
   PubMedGoogle Scholar
• PY Marque, A Daver, R Sapin, B Bridgi, JP Muratet, DJ Hartmann, F Paolucci, and B Pau. (1996). Highly sensitive immunoradio-metric assay for serum thyroglobulin with minimal interference from autoantibodies. Clin Chem 42:258–262.
   PubMedGoogle Scholar
• KA Kolquist, LW Ellisen, CM Counter, M Meyerson, LK Tan, RA Weinberg, DA Haber, and WL Gerald. (1998). Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nature Genet 19:182–186.
   PubMed Web of Science ®Google Scholar
• MT Siddiqui, KL Greene, DP Clark, S Xydas, R Udelsman, RC Smallridge, MA Zeiger, and M Saji. (2001). Human telomerase reverse transcriptase expression in Diff-Quik-stained FNA samples from thyroid nodules. Diag Mol Pathol 10:123–129.
   PubMedGoogle Scholar
• M Saji, S Xydas, WH Westra, CK Liang, DP Clark, R Udelsman, CB Umbricht, S Sukumar, and MA Zeiger. (1999). Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms. Clin Cancer Res 5:1483–1489.
   PubMedGoogle Scholar
• K Ohyashiki, JH Ohyashiki, J Nishimaki, K Toyama, Y Ebihara, H Kato, WE Wright, and JW Shay. (1997). Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay. Cancer Res 57:2100–2103.
   PubMed Web of Science ®Google Scholar
• TM Bryan, L Marusic, S Bacchetti, M Namba, and RR Reddel. (1997). The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum Mol Genet 6:921–926.
   PubMed Web of Science ®Google Scholar
• K Aogi, K Kitahara, V Urquidi, D Tarin, and S Goodison. (1999). Comparison of telomerase and CD44 expression as diagnostic tumor markers in lesions of the thyroid. Clin Cancer Res 5:2790–2797.
   PubMedGoogle Scholar
• JD Henson, JA Hannay, SW McCarthy, JA Royds, TR Yeager, RA Robinson, SB Wharton, DA Jellinek, SM Arbuckle, J Yoo, BG Robinson, DL Leaaroyd, PD Stalley, SF Bonar, D Yu, RE Pollock, and RR Reddel. (2005). Arobust assay for alternative lengthning of telomeres in tumors shows the significance of alternative lengthning of telomeres in sarcomas and astrocytomas. Clin Cancer Res 11:217–225.
   PubMed Web of Science ®Google Scholar
• LM Trulsson, AK Velin, A Herder, P Soderkvist, A Ruter, and S Smeds. (2003). Telomerase activity in surgical specimens and fine-needle aspiration biopsies from hyperplastic and neoplastic human thyroid tissues. Am J Surg 186:83–88.
   PubMedGoogle Scholar
• P Matthews, CJ Jones, J Skinner, M Haughton, C Micco, and D Wynford-Thomas. (2001). Telomerase activity and telomere length in thyroid neoplasia: Biological and clinical implications. J Pathol 194:183–193.
   PubMedGoogle Scholar
• MT Siddiqui, KL Greene, DP Clark, S Xydas, R Udelsman, RC Smallridge, MA Zeiger, and M Saji. (2001). Human telomerase reverse transcriptase expression in diff-cuik-stained FNA samples from thyroid nodules. Diag Mol Pathol 10:123–129.
   PubMedGoogle Scholar
• M Kammori, K Nakamura, M Hashimoto, T Ogawa, M Kaminishi, and K Takubo. (2003). Clinical application of human telomerase reverse transcriptase gene expression in thyroid follicular tumors by fine-needle aspirations using in situ hybridization. Int J Oncology 22:985–991.
   PubMedGoogle Scholar
• E Hesse, PB Musholt, E Potter, T Petrich, M Wehmeier, RV Wasielewski, R Lichtinghagen, and TJ Musholt. (2005). Oncofoetal fibronectin – a tumor-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma. Br J Cancer 93:565–570.
   PubMedGoogle Scholar
• H Land, LF Parada, and RA Weinberg. (1983). Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304:596–602.
   PubMed Web of Science ®Google Scholar
• R Aasland, JR Lillehaug, R Male, O Josendal, JE Varhaug, and K Kleppe. (1998). Expression of oncogenes in thyroid tumours: Coexpression of c-erbB2/neu and c-erbB. Br J Cancer 57:358–363.
   Google Scholar
• A Fusco, M Grieco, M Santoro, MT Berlingieri, S Pilotti, MA Pierotti, G Della Porta, and G Vecchio. (1987). A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases. Nature 328:170–172.
   PubMed Web of Science ®Google Scholar
• F Monaco, S Grimaldi, R Dominici, and J Robbins. (1975). Defective thyroglobulin synthes is in an experimental rat thyroid tumor: Iodination and thyroid hormone synthesis in isolated tumor thyroglobulin. Endocrinology 97:347–351.
   PubMedGoogle Scholar
• MW Goldberg, and TD Allen. (1992). High resolution scanning electron microscopy of the nuclear envelope: Demonstration of a new, regular, fibrous lattice attached to the baskets of the nucleoplasmic face of the nuclear pores. J Cell Biol 119:1429–1440.
   PubMedGoogle Scholar
• K Suzuki, S Lavaroni, A Mori, M Ohta, J Saito, M Pietrarelli, DS Singer, S Kimura, R Katoh, A Kawaoi, and LD Kohn. (1998). Autoregulation of thyroid-specific gene transcription by thyroglobulin. Proc Natl Acad Sci 95:8251–8256.
   PubMedGoogle Scholar
• HL Pahl, and PA Baeuerle. (1995). A novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NF-κB. EMBO J 14:2580–2588.
   PubMed Web of Science ®Google Scholar
• K Suzuki, M Nakazato, L Ulianich, A Mori-Aoki, M Ohta, E Moriyama, HK Chung, M Pietrarelli, A Grassadonia, H Matoba, and LD Kohn. (2000). Thyroglobulin autoregulation of thyroid-specific gene expression and follicular function. Rev Endocr Metab Disord 1:217–224.
   PubMedGoogle Scholar
• A Nagasaka, S Yoshida, A Nakai, T Ohyama, K Iwase, S Ohtani, H Nakagawa, R Masunaga, S Kato, T Kawabe, and K Kataoka. (1988). Hormonal regulation of DNA polymerase-beta activity in the rat thyroid gland. J Endocrinol 119:303–308.
   PubMedGoogle Scholar
• A Nagasaka, A Nakai, N Oda, M Kotake, K Iwase, and S Yoshida. (2000). Reverse transcriptase is elevated in the thyroid tissue from Graves' disease patients. Clin Endocrinol 53:155–159.
   PubMed Web of Science ®Google Scholar
• N Hayakawa, K Nozawa, A Ogawa, N Kato, K Yoshida, K Akamatsu, M Tsuchiya, A Nagasaka, and S Yoshida. (1999). Isothiazolone derivatives selectively inhibit telomerase from human and rat cancer cells in vitro. Biochemistry 38:11501–11507.
   PubMed Web of Science ®Google Scholar
• L Teng, MC Specht, CB Barden, and TJ Fahey3rd. (2003). Antisense hTERT inhibits thyroid cancer cell growth. J Clin Endocrinol Metab 88:1362–1366.
   PubMedGoogle Scholar
• T Takeda, H Inaba, M Yamazaki, S Kyo, T Miyamoto, S Suzuki, T Ehara, T Kakizawa, M Hara, LJ DeGroot, and K Hashizume. (2003). Tumor-specific gene therapy for undifferentiated thyroid carcinoma utilizing the telomerase reverse transcriptase promoter. J Clin Endocrinol Metab 88:3531–3538.
   PubMed Web of Science ®Google Scholar
• FS Wyllie, CJ Jones, JW Skinner, MF Haughton, C Wallis, D Wynford-Thomas, RGA Faragher, and D Kipling. (2000). Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nature Genetics 24:16–17.
   PubMed Web of Science ®Google Scholar